The group�s principle activity is to provide women's health pharmaceutical services. The group�s product includes low estrogen dose seven day transdermal contraceptive. The group operates from United States.
Executive Information
Name
Title
Email
Thomas Rossi
CEO, Pres.
N/A
Agis Kydonieus
Chief Scientific Officer
N/A
Marie Foegh
Chief Medical Officer, VP - Clinical Research, Development